Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Dynamic Anterior Stabilization vs Bankart Repair for recurrent shoulder instability

Official title: Comparative Outcomes of Arthroscopic Surgical Techniques in Anterior Shoulder Instability With Glenoid Bone Loss 10-20%

Run by Riga Stradins University · NCT07876232 · Data updated 2026-11-12

This study tests whether Dynamic Anterior Stabilization (DAS) or traditional Bankart repair better stabilizes the shoulder in people under 50 with recurring anterior instability and 10-20% glenoid bone loss.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment60 (estimated)
SponsorRiga Stradins University
Academic / other
Locations1 site (Riga)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedAugust 31, 2027
Study endsAugust 31, 2029
Registry record updatedOctober 15, 2026
Trial IDNCT07876232 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults ≤50 years with recurrent anterior shoulder instability, MRI-confirmed anterior labral injury, Hill-Sachs lesion, and 10-20% glenoid bone loss.

Probably not a fit

Patients with age >50, multifactorial shoulder instability, or substantial glenoid bone loss outside the 10-20% range may not benefit from these strategies.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center prospective comparison enrolls 60 participants with chronic anterior shoulder instability and subcritical glenoid bone loss (10-20%). Participants undergo random or programmatic allocation to either arthroscopic Bankart repair or Dynamic Anterior Stabilization (DAS) using the long head of the biceps tendon. Outcomes are measured preoperatively and at 1, 3, 6, 12, and 24 months using the Constant Score, ASES score, pain via VAS, and Oxford instability score, along with recurrence and return-to-activity data. The study also collects MRI/CT evaluations to characterize soft-tissue injury and bone loss. All procedures are performed arthroscopically by a single surgeon, with intraoperative tissue sampling for histopathology.

Why it matters

Potential benefit: If successful, the trial could clarify which surgical approach provides better stability and function for patients with subcritical bone loss, potentially guiding surgical decision-making.

How similar studies have gone: Prior research suggests both Bankart repair and DAS can improve stability, but direct head-to-head data in subcritical bone loss are limited, making this comparative study relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged ≤50 years;
* History of anterior shoulder dislocation and/or subluxation;
* Persistent anterior glenohumeral instability;
* MRI-confirmed anterior labral injury and Hill-Sachs lesion;
* CT-confirmed glenoid bone loss of 10-20% of the total glenoid articular surface.

Exclusion Criteria:

* Patients aged \>50 years;
* Concomitant injuries or pathological conditions involving other structures of the shoulder joint;
* Multidirectional shoulder instability;
* Previous surgical procedures on the affected shoulder;
* Acute infection;
* Coagulation disorders;
* Systemic diseases, including diabetes mellitus (DM), rheumatoid arthritis (RA), gout, and autoimmune diseases (AIDs).

Where it's running

  • ORTO Klīnika
    Riga, Latvia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.